食品伙伴網(wǎng)訊   據(jù)歐盟食品安全局（EFSA）消息，10月9日歐盟食品安全局就轉(zhuǎn)基因生物上市申請(qǐng)當(dāng)中涉及的90天喂養(yǎng)試驗(yàn)做了進(jìn)一步說(shuō)明。

    歐盟食品安全局的本次聲明建立在2011年發(fā)布的老鼠90天全食品/飼料研究指南文件當(dāng)中的原則基礎(chǔ)之上。

    本次聲明包括三大主要目標(biāo)，有助確保轉(zhuǎn)基因申請(qǐng)的一致性。歐盟食品安全局還對(duì)90天喂養(yǎng)試驗(yàn)的試驗(yàn)設(shè)計(jì)與方法提出了建議。

    部分原文報(bào)道如下：

    The European Food Safety Authority （EFSA） presents further details on how to design and conduct a 90-day feeding study as part of an application to place a genetically modified organism on the market in the European Union （EU）。 The explanatory statement builds on the principles set out in EFSA's previous guidance document on 90-day whole food/feed studies in rodents published in 2011.

    EFSA's statement has three main objectives. Firstly, it clarifies the possible approaches for carrying out whole food and feed 90-day studies in GM plant risk assessment within the new regulatory context. Secondly, the document gives detailed instructions on how to apply the general principles presented in EFSA's 2011 guidance for 90-day whole-food/feed studies, describing technical details such as the choice of test materials, dose levels and environmental conditions for test animals. It also provides instructions on the collection, interpretation and reporting of data. The statement seeks to ensure consistency among the GM applications submitted to the Authority.

    原文鏈接：<http://www.efsa.europa.eu/en/press/news/141009.htm>